Skip to main content
. 2020 Aug 10;22(9):1311–1319. doi: 10.1093/europace/euaa126

Figure 4.

Figure 4

Temporals trend of the prescription of DOACs and VKA for patients with AF by CHA2DS2-VASc score, 2011–2018. AF, atrial fibrillation; DOAC, direct OAC; OAC, oral anticoagulants; VKA, vitamin K antagonists.